NCT05228470 2026-01-06
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
Pfizer
Phase 2 Completed
Clinical Trials
9 trialsNCT03935282 2025-12-15
AH-HA
Wake Forest University Health Sciences
Phase NA Completed
NCT07041827 2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
NCT05850013 2024-07-18
VISION-Jr
Xim Limited
Completed
NCT05130489 2023-05-12
CARTCO
University College London Hospitals
Completed
NCT00428688 2023-04-12
Endothelial Function and IMT in Survivors of Hodgkin's Lymphoma
Sheba Medical Center
Completed
NCT00773747 2021-04-30
Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT01733953 2016-12-14
Statin Therapy in Young Adult Survivors of Childhood Cancer
University of Minnesota
Phase 2 Completed
NCT00725634 2014-01-27
P05538
AVEO Pharmaceuticals, Inc.
Phase 1 Completed